Moberg hires chief medical officer
This article was originally published in OTC Bulletin & The Rose Sheet
Sweden’s Moberg Pharma has hired Shaw Sorooshian as its vice president and chief medical officer. He will join Moberg “during the fall” from his current position as senior director of global medical affairs at biopharmaceutical company Sobi.
You may also be interested in...
After most of the big pharmaceutical companies reported their full-year 2019 financial results, the second month of earnings season brings the long tail of smaller biotech companies and the generic pharmaceutical companies. There is more than one uncomfortable parallel from the former in the reports of the latter.
The HMA-EMA Big Data Task Force has offered recommendations to use data for the benefit of public health.